⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16592874 | 0.78 | ACE (0.31) | — | |
| SCHEMBL1272915 | 0.76 | — | — | |
| SCHEMBL1684937 | 0.76 | — | — | |
| SCHEMBL4426720 | 0.75 | PTGS1 (0.33) | — | |
| SCHEMBL18784627 | 0.67 | ACE (0.32) | — | |
| SCHEMBL1019147 | 0.65 | — | — | |
| SCHEMBL6260834 | 0.64 | MGLL (0.32) | — | |
| SCHEMBL23706381 | 0.61 | — | — | |
| SCHEMBL45794 | 0.59 | PTGS1 (0.33) | — | |
| SCHEMBL4974653 | 0.59 | PTGS1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2197783-B1 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIV INDUSTRY FOUNDATION (KR) | 2018-07-11 | — | — | EP | claimed |
| US-20150165060-A1 | PEPTIDE HAVING CANCER SELECTIVE TRANSLOCATION FUNCTION AND USE THEREOF | SNU R&DB FOUNDATION (KR) | 2015-06-18 | — | — | US | claimed |
| EP-2399939-B1 | TARGET ACTIVATED CELL/TISSUE TRANSLOCATION PEPTIDE FOR IMPERMEABLE COMPOUND STRATEGY, AND USES THEREOF | NANO INTELLIGENT BIOMED ENG (KR) | 2015-04-01 | — | — | EP | claimed |
| US-8796219-B2 | Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof | NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD (KR) | 2014-08-05 | — | — | US | claimed |
| US-20120053129-A1 | TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF | NANO INTELLIGENT BIOMEDICAL ENGINEERING (KR) | 2012-03-01 | — | — | US | claimed |
| EP-2399939-A2 | TARGET ACTIVATED CELL/TISSUE TRANSLOCATION PEPTIDE FOR IMPERMEABLE COMPOUND STRATEGY, AND USES THEREOF | Nano Intelligent Biomedical Engineering Corporation Co., Ltd. (KR) | 2011-12-28 | — | — | EP | claimed |
| US-20100298536-A1 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2010-11-25 | — | — | US | claimed |
| EP-2197783-A2 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | Seoul National University Industry Foundation (KR) | 2010-06-23 | — | — | EP | claimed |
| WO-2009045063-A2 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-09 | — | — | WO | claimed |
| WO-2024029981-A1 | LIPID NANOPARTICLES COMPRISING LONG-CHAIN CERAMIDE AND COMPOSITION FOR CELL DEATH COMPRISING SAME | 주식회사 무진메디 | 2024-02-08 | — | — | WO | disclosed |
| EP-3498291-B1 | PHARMACEUTICAL COMPOSITION AND BIOMATERIAL COMPRISING FUSION PEPTIDE HAVING PARATHYROID HORMONE (PTH) CONJUGATED WITH PEPTIDE SELECTIVE FOR BONE TISSUE | NIBEC CO LTD (KR) | 2024-01-03 | — | — | EP | disclosed |
| US-11766485-B2 | Nanoliposome-microbubble conjugate having complex of Cas9 protein, guide RNA inhibiting SRD5A2 gene expression and cationic polymer encapsulated in nanoliposome and composition for ameliorating or treating hair loss containing the same | MOOGENE MEDI CO., LTD. (KR) | 2023-09-26 | — | — | US | disclosed |
| US-20230279143-A1 | PROTEIN COMPRISING ANTIBODY FOR TARGETING ONCOGENIC PROTEIN OR SINGLE CHAIN FRAGMENT VARIABLE THEREOF AND CANCER CELL PENETRATING PEPTIDE, AND USE OF THE SAME | NIBEC CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| EP-4198058-A1 | ANTIBODY TARGETING INTRACELLULAR TUMOR-INDUCING PROTEIN, OR FUSION PROTEIN OF SINGLE STRAND VARIABLE FRAGMENT THEREOF AND CANCER-CELL-PENETRATING PEPTIDE, AND USE THEREOF | Nibec Co., Ltd. (KR) | 2023-06-21 | — | — | EP | disclosed |
| US-20120053129-A1 | TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF | NANO INTELLIGENT BIOMEDICAL ENGINEERING (KR) | 2012-03-01 | — | — | US | disclosed |
| EP-2399939-A2 | TARGET ACTIVATED CELL/TISSUE TRANSLOCATION PEPTIDE FOR IMPERMEABLE COMPOUND STRATEGY, AND USES THEREOF | Nano Intelligent Biomedical Engineering Corporation Co., Ltd. (KR) | 2011-12-28 | — | — | EP | disclosed |
| US-20100298536-A1 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2010-11-25 | — | — | US | disclosed |
| EP-2197783-A2 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | Seoul National University Industry Foundation (KR) | 2010-06-23 | — | — | EP | disclosed |
| WO-2009045063-A2 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009045062-A1 | CELL PERMEABLE FUSION PROTEIN FOR FACILITATING OSSIFICATION AND USE THEREOF | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-09 | — | — | WO | disclosed |